You are here

China

AstraZeneca continues to build out its presence in China with new COPD drug manufacturing site

Endpoints

Wed, 06/22/22 - 06:55 pm

drug manufacturing

Merck snaps up cancer drug from China’s Kelun in $1.4bn deal

Pharmaforum

Wed, 05/18/22 - 11:53 pm

immuno-oncology

Sichuan Kelun Pharmaceutical

Merck KGaA warns of volatile 2022 thanks to war in Ukraine and fresh COVID lockdowns in China

Fierce Pharma

Thu, 05/12/22 - 10:49 am

GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in conviction

Fierce Pharma

Tue, 05/3/22 - 10:39 am

Quiet CDMO makes noise, throwing down $500M for manufacturing campus and moving forward with China operations

Endpoints

Tue, 04/12/22 - 08:37 pm

drug manufacturing

Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply

Endpoints

Wed, 03/30/22 - 10:59 am

Another strike for biotech: China

EP Vantage

Mon, 03/14/22 - 10:18 am

foreign inspections

Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market

Fierce Biotech

Thu, 02/17/22 - 10:56 am

Innovent Biologics

clinical trials

FDA sends signal with tough questions of Lilly at cancer drug meeting

BioPharma Dive

Thu, 02/10/22 - 10:37 pm

Innovent Biologics

clinical trials

China-Developed Drugs for U.S. Market Could Face Steep Hill

BioSpace

Wed, 02/9/22 - 11:01 am

clinical trials

AstraZeneca reveals insurance fraud probe in China as officials say they've made criminal arrests

Fierce Pharma

Mon, 01/31/22 - 10:43 am

Clover Biopharmaceuticals sets up a new R&D center in a buzzy Chinese hub near Shanghai

Endpoints

Wed, 01/5/22 - 10:44 pm

Clover BioPharmaceuticals

Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect

Fierce Biotech

Tue, 12/21/21 - 10:34 am

Omecamtiv Mecarbil

Ji Xing Pharmaceuticals

Novartis Deepens BeiGene Oncology Pact, Posts Disappointing Results in CSU

BioSpace

Mon, 12/20/21 - 10:49 am

Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data

Endpoints

Fri, 12/17/21 - 10:52 am

Connect Biopharma

clinical trials

Biotech BeiGene slides in Shanghai after $3.5 bln STAR debut

Yahoo/Reuters

Wed, 12/15/21 - 10:39 am

Eli Lilly pens $1.5B biobucks pact with China's Regor for metabolic disease work

Fierce Biotech

Fri, 12/10/21 - 11:05 am

Regor Therapeutics

metabolic disorders

Drugmakers cut prices on average by more than 60% to get on China's 2022 NDRL list — report

Endpoints

Fri, 12/3/21 - 10:37 am

After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas

Endpoints

Tue, 11/30/21 - 10:26 am

Ablaze Pharmaceuticals

radiopharmaceuticals

Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze

Fierce Pharma

Mon, 11/29/21 - 10:55 pm

Pages